AstraZeneca
NYSE AZN · Cambridge, United Kingdom
Works in Cardiovascular · Dermatology · ENT · Genetic & rare · GI & liver · Hematology · Immunology · Infectious disease · Metabolic & endocrine · Musculoskeletal · Neurology · Oncology · Ophthalmology · Psychiatry · Renal & urogenital · Respiratory · Women's health
AstraZeneca is a clinical trial sponsor based in Cambridge, United Kingdom, listed as NYSE AZN. It has 496 active clinical trials with 26,551,038 planned participants, across 17 therapeutic areas. Since 2021 it has completed 688 trials and stopped 92 early.
Trial track record · since 2021
Financials · NYSE AZN
Fundraising
No SEC Form D filings under this name. A private round is only public when the company files one.
Pipeline · 496 active trials
| Stage | Trial | Status |
|---|---|---|
On the market · 33 products
- AIRSUPRA albuterol sulfate, budesonide · NDA 214070 · prescription
- TAGRISSO osimertinib mesylate · NDA 208065 · prescription
- SYMBICORT budesonide, formoterol fumarate dihydrate · NDA 021929 · prescription
- NEXIUM esomeprazole magnesium · NDA 021957 · prescription
- KOSELUGO selumetinib · NDA 219943 · prescription
- SEROQUEL quetiapine fumarate · NDA 020639 · prescription
- KOSELUGO selumetinib sulfate · NDA 213756 · prescription
- IRESSA gefitinib · NDA 206995 · prescription
- SAPHNELO anifrolumab-fnia · BLA 761451 · prescription
- IMFINZI durvalumab · BLA 761069 · prescription
- FASENRA benralizumab · BLA 761070 · prescription
- CALQUENCE acalabrutinib · NDA 210259 · prescription
- LYNPARZA olaparib · NDA 208558 · prescription
- BRILINTA ticagrelor · NDA 022433 · prescription
- SEROQUEL XR quetiapine fumarate · NDA 022047 · prescription
- FASLODEX fulvestrant · NDA 021344 · prescription
- LOKELMA sodium zirconium cyclosilicate · NDA 207078 · prescription
- SAPHNELO anifrolumab-fnia · BLA 761123 · prescription
- CALQUENCE acalabrutinib maleate · NDA 216387 · prescription
- CRESTOR rosuvastatin calcium · NDA 021366 · prescription
- NEXIUM esomeprazole magnesium · NDA 022101 · prescription
- DALIRESP roflumilast · NDA 022522 · prescription
- BEVESPI AEROSPHERE formoterol fumarate, glycopyrrolate · NDA 208294 · prescription
- ETCAMAH camizestrant · NDA 220359 · prescription
- BREZTRI AEROSPHERE budesonide, formoterol fumarate, glycopyrrolate · NDA 212122 · prescription
- XIGDUO XR dapagliflozin, metformin hydrochloride · NDA 205649 · prescription
- TRUQAP capivasertib · NDA 218197 · prescription
- WAINUA (AUTOINJECTOR) eplontersen sodium · NDA 217388 · prescription
- WAINUA eplontersen sodium · NDA 217388 · prescription
- IMJUDO tremelimumab-actl · BLA 761289 · prescription
- NEXIUM esomeprazole magnesium · NDA 021153 · prescription
- FARXIGA dapagliflozin · NDA 202293 · prescription
- PULMICORT RESPULES budesonide · NDA 020929 · prescription
Questions about AstraZeneca
AstraZeneca is lead sponsor of 496 active clinical trials on ClinicalTrials.gov, with 26,551,038 planned participants, in Cardiovascular, Dermatology, ENT, Genetic & rare and other areas. Since 2021 it has completed 688 trials and stopped 92 early.
AstraZeneca is based in Cambridge, United Kingdom and is listed as NYSE AZN. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with AstraZeneca; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-16.
Products come from FDA's drug application database and, for vaccines, cell and gene therapies and blood products, FDA's Purple Book of licensed biologics; checked 2026-09-23.
Approve Suite is not affiliated with AstraZeneca. Informational only.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.